Artelo Biosciences appoints Mark Spring as CFO effective November 1, 2025

ARTELO BIOSCIENCES, INC.

Spring replaces Gregory Gorgas as principal financial officer and treasurer; Gorgas remains CEO.
Spring receives $250,000 base salary, 35% target bonus, and severance of 12 months base salary (18 months on change in control).
Gorgas amended agreement: severance increased to 24 months base salary and target bonus (36 months during CIC protection period).
Gorgas now eligible for severance on constructive termination outside CIC period; vesting provisions revised for post-Effective Date grants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.